Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.52K Sell
10
-26
-72% -$9.27K ﹤0.01% 296
2025
Q4
$11.8K Buy
36
+25
+227% +$7.93K ﹤0.01% 294
2025
Q3
$3.1K Hold
11
﹤0.01% 284
2025
Q2
$3.07K Buy
11
+1
+10% +$283 ﹤0.01% 275
2025
Q1
$3.12K Hold
10
﹤0.01% 267
2024
Q4
$2.61K Hold
10
﹤0.01% 287
2024
Q3
$3.22K Hold
10
﹤0.01% 281
2024
Q2
$3.13K Hold
10
﹤0.01% 276
2024
Q1
$2.84K Hold
10
﹤0.01% 305
2023
Q4
$2.88K Hold
10
﹤0.01% 286
2023
Q3
$2.69K Hold
10
﹤0.01% 282
2023
Q2
$2.22K Hold
10
﹤0.01% 286
2023
Q1
$2.42K Sell
10
-93
-90% -$22.8K ﹤0.01% 288
2022
Q4
$27.1K Buy
103
+93
+930% +$24.9K 0.02% 217
2022
Q3
$2K Hold
10
﹤0.01% 282
2022
Q2
$2K Hold
10
﹤0.01% 287
2022
Q1
$2K Hold
10
﹤0.01% 299
2021
Q4
$2K Hold
10
﹤0.01% 305
2021
Q3
$2K Buy
+10
New +$2.3K ﹤0.01% 297

Other funds holding AMGN

Legacy Bridge's AMGN Position: Q1 2026 in Review

Legacy Bridge reduced its Amgen (AMGN) stake by 72% in Q1 2026, selling an estimated $9.27K and leaving 10 shares worth $3.52K. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Legacy Bridge first reported a position in AMGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $27.1K in Q4 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Legacy Bridge held 10 shares of Amgen worth $3.52K as of Q1 2026.
  • Legacy Bridge sold 26 Amgen shares in Q1 2026, an estimated $9.27K.
  • Amgen made up ﹤0.01% of Legacy Bridge's portfolio in Q1 2026, its #296 holding.
  • Legacy Bridge first reported a position in Amgen in Q3 2021 and has held it in 19 quarters since.
  • Legacy Bridge's Amgen position peaked at $27.1K in Q4 2022.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.